1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE
ACT OF 1934
Date of Report (Date of earliest event reported)
July 17, 1998 (July 15, 1998)
ABGENIX, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation or organization)
000-24207 94-3248826
Commission File Number (I.R.S. Employer Identification Number)
7601 Dumbarton Circle
Fremont, California 94555
(Address of principal executive offices)
(510) 608-6500
(Registrant's telephone number, including area code)
2
ABGENIX, INC.
FORM 8-K
JULY 17, 1998
Item 5. Other Events
On July 15, 1998, the Registrant announced that on that date it entered
into a Research Collaboration Agreement with Millennium Biotherapeutics, Inc. to
develop antibody products for an undisclosed antigen in the field of
inflammatory disease.
The press release and the Research Collaboration Agreement between the
Registrant and Millennium Biotherapeutics, Inc. have been filed as exhibits to
this Report on Form 8-K.
-2-
3
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunder duly authorized.
ABGENIX, INC.
Date: July 17, 1998 /s/ R. Scott Greer
-------------------------------------
R. Scott Greer
President and Chief Executive Officer
-3-
4
Item 7. Financial Statements and Exhibits
(c) Exhibits (in accordance with Item 601 of Regulation S-K)
+10.1 Research Collaboration Agreement dated July 15, 1998
between Millennium Biotherapeutics, Inc. and the Registrant.
99.1 Press Release of the Registrant regarding the signing of the
Research Collaboration Agreement with Millennium
Biotherapeutics, Inc.
+ Confidential treatment requested for portions of this exhibit. Omitted
portions have been filed separately with the Commission.
-4-
5
ABGENIX, INC.
Report on Form 8-K
dated July 17, 1998
INDEX TO EXHIBITS
EXHIBIT
NUMBER EXHIBIT NAME
- --------- ----------------------------------------------------------------------
+10.1 Research Collaboration Agreement dated July 15, 1998 between
Millennium Biotherapeutics, Inc. and the Registrant.
99.1 Press Release of the Registrant regarding the signing of the Research
Collaboration Agreement with Millennium Biotherapeutics, Inc.
- ----------
+ Confidential treatment requested for portions of this exhibit. Omitted
portions have been filed separately with the Commission.
-5-